Read + Share
Amedeo Smart
Independent Medical Education
Ma J, van Doodewaerd BR, Biersack B, Verbon A, et al. A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-kappaB inhibitors active against eumycetoma. J Antimicrob Chemother 2025;80:3320-3328.PMID: 41016854
Email
LinkedIn
Privacy Policy